Apr 27, 2017
Overview
The Gynecologic Oncology Program at Smilow Cancer Hospital, part of Yale Cancer Center, is focused on delivering comprehensive and compassionate healthcare to women diagnosed with various gynecologic cancers. This program caters to patients with vulvar, vaginal, cervical, uterine, fallopian tube, and ovarian cancers, employing a multidisciplinary approach for diagnosis, treatment, and care.
Specialists actively involved in the program include experienced gynecologic oncologists and healthcare professionals from various disciplines, ensuring the provision of personalized patient care. These healthcare providers are dedicated to not only treating cancer but also addressing the associated psychological and emotional needs of each patient.
Clinical Focus and Special Programs
The Gynecologic Oncology Program extends its specialty beyond traditional gynecologic cancers, including treatments for soft tissue tumors of the pelvis and gestational trophoblastic disease. It also addresses precancerous conditions affecting the vulva, vagina, cervix, and endometrium, focusing on comprehensive management strategies and early detection programs, such as the Ovarian Cancer Early Detection Program.
Minimally Invasive Gynecological Surgery Program
One of the program's innovative approaches includes a Minimally Invasive Gynecological Surgery Program, which aims to reduce recovery time and surgical complications, therefore improving the overall patient experience.
Education and Training
As a premier educational institution, Yale Cancer Center also provides various educational programs aimed at training future leaders in the field of gynecologic oncology. Residents and fellows have the opportunity to engage in research, clinical care, and hands-on training in a structured environment that emphasizes both medical and surgical oncology.
Research Opportunities
The program is deeply involved in research modalities that emphasize translating scientific advancements into patient care. Active clinical trials allow patients access to cutting-edge treatments that could potentially offer better outcomes. This commitment to research and education is crucial in advancing gynecologic cancer care.
Visa Support and International Applicants
The Gynecologic Oncology Program is committed to supporting international medical graduates and offers relevant visa sponsorship, including J-1 and H-1B visa types. This dedication to increasing diversity within the program creates a more inclusive learning and patient-care environment.
Competitiveness and Application Requirements
This program is highly competitive, welcoming both MDs and DOs, as well as international medical graduates. Applicants should be mindful of special requirements, including no more than one failed USMLE Step exam and a graduation year not exceeding five years. A strong applicant profile typically includes relevant clinical experience and a demonstrated commitment to women's health.
Clinical Rotations and Training Sites
Training occurs through a well-structured curriculum encompassing diverse clinical rotations. The primary training site, Smilow Cancer Hospital, is equipped with state-of-the-art technology and staffed by a multidisciplinary group of experts devoted to treating gynecologic cancers.
Web sources
SmartPick
Program data
ACGME History [2]
Program
Program Size
1, 1, 1 (3 years) [1]
Accreditation Status
Continued Accreditation
(Effective: April 27, 2026)
Composition
--
Training
Fellowship Rate:--
Faculty-to-Residents Ratio:--
Residents Career Path
--
Quality of Life
First Year Paid Sick Leave: --
First Year Paid Vacation: --
First Year Salary: --
First Year Maximum Consecutive Hours on Duty: 10 hours [1]
First Year Average Weekly Hours: 80 hours [1]
Admission
USMLE Step 2 Score: --
Visa Sponsorship:--
YOG Cutoff:--
Race / Ethnicity
No race data available.
Gender
No gender data available.
Incoming Schools
No incoming school data available.
Rotation Duration by Site
Benchmarks
Roster
Publications
7 Publications (5 yr)
Peer-reviewed output from faculty and residents, last 5 years
7 Publications (5 yr)
Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective Study.
The multidisciplinary management of a patient with infected iliocaval stents and uterine cancer invasion.
Location
New Haven, CT [4]
- Above the national average
- Below the national average
- Similar to the national average
Housing — Rental prices [5]
Rental prices
Crime — All violent offences [6]
Rate per 100,000 residents
FAQ
Ready to Find Your Ideal Residency Program?
Get a personalized, data-driven program list built around your scores, experiences, and visa needs.
Nearby programs
Gynecologic oncology Programs Near New Haven, CT
Other specialties near New Haven, CT
References
1. Freida - https://freida.ama-assn.org/program/2250822002
2. ACGME - Accreditation Data System (ADS) - https://apps.acgme.org/ads/Public/Programs/Search
3. NRMP Results and Data: 2022-2026 Main Residency Match - https://www.nrmp.org/match-data/2026/03/program-results-2022-2026/
4. United States Census Bureau - https://data.census.gov/profile/City,_VS?g=010XX00US
5. Zillow Research - Observed Rent Index (ZORI) - https://www.zillow.com/research/data/
6. FBI - Crime/Law Enforcement Stats (Uniform Crime Reporting Program) - https://www.fbi.gov/services/cjis/ucr